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THE NEUROHISTOLOGY OFPAINFUL AND PAIN-FREE ROTATOR CUFF
TENDONS: A CASE CONTROL STUDY
B.J. Dean, S.L. Franklin, R.J. Murphy, R. Benson, K. Javaid, A.J. Carr. Univ.
of Oxford, Oxford, United Kingdom
Purpose:Our main purpose was to compare the tendon neurohistology
in two groups of patients; one with signiﬁcant pain prior to undergoing
SAD and one with resolved pain over 6 years post SAD.
Methods: Supraspinatus tendon specimens were obtained using an
ultrasound guided biopsy technique from 9 patients with painful RCT
resistant to conservative management (painful group) and 9 pain-free
patients at over 6 years (median 6 years 11 months) following SAD
(pain-free group). Pain symptoms were measured using the validated
Oxford Shoulder Score (OSS). Structural tendon integrity was assessed
ultrasonographically. The tendon tissue was analysed using basic his-
tological techniques (Haematoxylin and Eosin, and Alcian Blue) and
Immunohistochemistry. Image analysis was performed by two blinded
observers using Image-J to quantify the amount of 3,3’-dia-
minobenzidine staining present. Isotype controls were also processed.
Mann-Whitney U tests were carried out using SPSS with signiﬁcance
levels set at a minimum of p < 0.05.
Results: The groups were similar in terms of age, sex and structural
tendon abnormality. The painful group consisted of 7 males and 2
females, the pain-free group of 6 males and 3 females. The mean age of
the painful group was 50 years (range 38 to 61) and that of the pain-free
group was 53 years (range 39 to 65). The median OSS in the painful
group was 32 (range 23 to 34) and this was signiﬁcantly lower (p ¼
0.0002) than the median OSS in the pain-free group (all 48). There were
two partial thickness tears in both groups and no full thickness tears.
The modiﬁed Bonar scores in the painful and the pain-free groups were
comparable. There were no signiﬁcant differences between groups in
terms of cellularity, vascularity, proliferation and hypoxia inducible-
factor 1a expression. The leucocyte count (CD45 positive cells) and
macrophage count (CD68 positive cells) were increased in the painful
group versus pain-free (p ¼ 0.01 and 0.05 respectively). The expression
of the metabotropic glutamate receptor 7 (mGluR7) was reduced in the
painful group versus pain-free (p ¼ 0.008 and 0.002 respectively). PGP
9.5 (a nerve marker) expression was increased in the painful group
versus pain-free (p ¼ 0.008). There were no signiﬁcant differences in
glutamate, the inotropic glutamate receptor (NMDAR1) and the
metabotropic glutamate receptors (mGluR1, 2 and 5) between groups.
Conclusions: This study has shown that speciﬁc characteristics of
tendon histology are associated with a resolution of shoulder pain over
six years following SAD. This provides strong evidence that the rotator
cuff tendon is of key importance in the symptomatology of RCT. The
mechanism behind these tendon differences remains unclear. These
ﬁndings are novel and improve our understanding of pain in RCT, and
may help provide novel therapeutic targets.
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NEGATIVE CORRELATION BETWEEN THE POPULATION OF CD105
POSITIVE SUBSET OF MONOCYTES/MACROPHAGES IN SYNOVIAL
FLUID AND THE SEVERITY OF JOINT PAIN AFTER ANTERIOR
CRUCIATE LIGAMENT RECONSTRUCTION SURGERY
K. Nakamura y, K. Tsuji z, H. Katagiri y, M. Inoue x, K. Abula y, I. Sekiya k,
T. Muneta y. yDept. of Joint Surgery and Sports Med., Tokyo Med. and
Dental Univ., Tokyo, Japan; zDept. of Cartilage Regeneration, Tokyo Med.
and Dental Univ., Tokyo, Japan; xDept. of Plastic Reconstructive and
Aesthetic Surgery, Tokyo Med. and Dental Univ., Tokyo, Japan; kCtr. for
Stem Cell and Regenerative Med., Tokyo Med. and Dental Univ., Tokyo,
Japan
Purpose: Synovial ﬂuid is an interstitial ﬂuid secreted by ﬁbroblastic
cells in the synovial membrane. The physiological functions of synovial
ﬂuid include reduction of friction, shock absorption, nutrient, and waste
transportation in the joint. In addition, previous studies showed that
mesenchymal stem cells (MSCs), those are considered to contribute the
tissue regeneration, reside in synovial ﬂuid and the number of these
cells increased after joint injury. These data strongly suggest that boththe contexts of cytokines and cellular components in synovial ﬂuid may
greatly inﬂuence the recovery process after joint injury or surgery.
In this study, we aimed to analyze the dynamic changes of cellular
components in synovial ﬂuid after anterior cruciate ligament recon-
struction surgery (ACL-R) and compared them with the clinical con-
ditions such as joint pain of each patient. Here we report that the
population of CD105þ subset of Monocytes/Macrophages negatively
correlates with the severity of joint pain in the early stage of recovery
process after ACL-R.
Methods: This study was approved by the Ethics Committee of Tokyo
Medical and Dental University. All patients enrolled in this study, who
underwent ACL-R from March till July 2013 in our university hospital,
gave their full, written, informed consent for participation prior to the
operative procedure (16 cases, Male:11, Female:5, 13-44 year-old,
Median:21.5 year-old). Synovial ﬂuid was obtained at day 4 to 5 after
surgery and cellular components were analyzed by ﬂow-cytometry (BD
FACS Verse). To evaluate the severity of joint pain semi-quantitatively,
we collected Numerical Rating Scale (NRS) Visual Analog Scale (VAS) of
each patient at day 4 to 5 after surgery (severity of joint pain when the
patient woke up). Pearson’s correlation coefﬁcient test was employed
for the statistical analysis and values of p < 0.05 were considered
signiﬁcant.
Results: Flow-cytometric analyses detectedCD3þTcells, CD56þNatural
Killer (NK) cells, CD66bþ Granulocytes, CD11bþCD14þ Monocytes/
Macrophages, and CD44þCD73þCD90þCD105þ MSCs in the synovial
ﬂuid at day 4 to 5 after ACL-R, although the population of each cell varied
in patients. Population of CD19þ B cells was almost undetectable in all
the patients analyzed. Pearson’s correlation coefﬁcient test revealed
that VAS was negatively correlated with the population of CD105þ cells
in synovial ﬂuid (r ¼ -0.52, p < 0.05). Since we did not observe
signiﬁcant negative correlation between VAS and the population of
CD44þCD73þCD90þCD105þ cells, those are less than 10% of total
CD105þ cells, we speculated that the CD105þ cells those do not have
characteristics of MSCs may have roles in joint pain. Further analyses
indicated that CD105þ cells did not co-express CD3, CD56, and CD66b.
Howevermore than 90% of CD105þ cells co-expressed CD11b and CD14,
suggesting that these cells are a subset of Monocyte/Macrophages.
Positive rate of CD105 in total CD11bþCD14þ cells was almost 10%.
Conclusions: Here we showed that the population of CD105þ subset of
Monocytes/Macrophages was negatively correlated with the severity of
joint pain after ACL-R. We expect that the functional analyses of these
cells may give us information to understand the molecular mechanism
of joint pain.
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ALTERATIONS IN CENTRAL PAIN PROCESSING ARE NOT RESTRICTED
TO END STAGE OSTEOARTHRITIS IN THE MONOSODIUM
IODOACETATE MODEL
L.N. Nwosu, P.I. Mapp, V. Chapman, D.A. Walsh. Univ. of Nottingham,
Nottingham, United Kingdom
Purpose: Osteoarthritis is a group of conditions that causes chronic
pain and disability. Mechanisms of central sensitization contribute to
the manifestation of aberrant pain responses such as mechanical
allodynia and spread of pain beyond the area of tissue damage.
Although evidence for central facilitation of pain has been noted in
patients undergoing joint replacement for OA, its contribution to early,
less severe OA is uncertain. OA severity can be evaluated by the mac-
roscopic appearance of articular surfaces, or microscopic changes in
tissue sections. It remains unclear which pathological features mediate
OA pain, and therefore the deﬁnition of structural disease severity is
problematic. The aim of this study was to model OA of differing
structural severity by intra-articular injections of low (0.1 mg) and
standard doses (1 mg) of monosodium-iodoacetate (MIA) in the rat and
to investigate associations between structural features of OA and pain
responses.
Methods: Male Sprague-Dawley rats (n ¼ 8/group, 330-450g) were
anaesthetised and given a single intra-articular injection of 50 ml MIA
(0.1 mg or 1 mg) or saline. Pain behaviour was assessed as difference in
hind limb weight bearing (%) and mechanical allodynia (hind paw
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S421withdrawal threshold (PWT: g) using calibrated Von Frey hairs) at 0, 3,
7, 9, 14, 16 and 20 days post-injection. Alterations in knee joint structure
(cartilage and synovium) were examined by macroscopic visualisation
of articular surfaces (Guingamp classiﬁcation), histology or immuno-
histochemistry. Differences between groups were analysed using
Kruskal Wallis test followed by post hoc Dunn’s test. Data are presented
as mean (95% conﬁdence interval). Data for correlations between pain
and pathology were obtained using pain behaviour scores observed at
day of sacriﬁce. Data are presented as Spearman’s correlation
coefﬁcients.




Weight bearing difference (%) 49.8 (14-85.5) 52.8 (4.78-101) 189 (118-261)* ++ n/a -0.44x
PWT (g) 282 (265-298) 187 (115-259)* 187 (160-215)** -0.44x n/a
Inﬂammation
Synovitis 0.7 (-0.2-1.6) 1.6 (0.9-2.4) 2.5 (2.1-2.9)** 0.27 -0.39
Macrophage area (%) 7.1 (2.9-11) 7.8 (5.1-11) 16 (11-22)* + 0.34 -0.21
Joint pathology
Macroscopic chondropathy 3.4 (1.8-5) 9.2 (7.4-11)** 11 (8.4-13)*** 0.44xx -0.28
Cartilage damage 0.5 (0.2-0.9) 2.2 (1.6-2.9)** 3.6 (1.3-5.9)*** 0.31 -0.51x
Chondrocyte morphology 0.4 (0.3-0.6) 2.1 (1.5-2.6)** 2.3 (1.9-2.6)** 0.15 -0.52x
Proteoglycan loss (Safranin-O-fast green) 2.0 [1.8-2.2) 2.4 (2.0-2.8)* 2.7 (2.4-2.9)** 0.07 -0.37
Proteoglycan loss (Alcian blue-PAS) 0.6 (0.4-0.8) 0.7 (0.38-1) 1.4 (1.1-1.8)*** ++ 0.15 0.07
Intra-articular injection of MIA produced marked changes in pain behaviour (increase in % weight bearing difference between left and right hind limb and decrease in PWT)
and pathology. MIA-induced changes in pain behaviour correlated with changes in macroscopic and microscopic pathology.
***p < 0.001 compared to saline control, ++p < 0.01 compared to 0.1 mg MIA and *p < 0.05 compared to saline control.Conclusions: Structural pathology and pain behaviour were dependent
on the dose of MIA used. Pain behaviour was associated with severity of
structural pathology. The 0.1 mg dose of MIA produced less severity in
both pathology and pain behaviour. Reduced mechanical PWT indi-
cating allodynia, in the absence of pronounced weight bearing asym-
metry may suggest that mechanisms other than ongoing nociceptive
input mediate distal allodynia in the low dose MIA model. Our results
show that central augmentation of pain is not restricted to late, struc-
turally severe OA following MIA injection in rats.
Pain: Treatment
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THE EFFECT OF RESINIFERATOXIN PRETREATMENT ON PAIN
MEASURED BY DYNAMIC WEIGHT BEARING AND EVOKED PAIN
RESPONSES IN AN ACUTE INFLAMMATORY MURINE ARTHRITIS
MODEL
H.E. Krug y,z, M. Abdullah z, S. Funkenbusch y, C.W. Dorman y,
S.P. Frizelle y, M.L. Mahowald y,z. yVA Hlth.Care System, Minneapolis, MN,
USA; zUniv. of Minnesota, Minneapolis, MN, USA
Purpose: Activation of vanilloid receptors by intra-articular (IA) Cap-
saicin (CAP) injection normalizes Evoked Pain Scores (EPS) and
Dynamic Weight Bearing (DWB) measures in carrageenan-induced
acute inﬂammatory arthritis. Resiniferatoxin (RTX) is an ultrapotent
CAP analogue that has a similar mechanism of action, and may have
greater efﬁcacy on carrageenan-induced arthritis when administered
intra-articularly. We hypothesized that mice with acute arthritis
would have measurable changes in DWB and EPS due to joint pain,
and that these changes could be prevented by pre-treating with IA
RTX.
Methods: Acute inﬂammatory arthritis was produced in C57Bl6mice by
IA injection of 10 ml of 2.5% carrageenan into the left knee 3 hours prior
to pain behavior testing. Two groups of mice were injected with dif-
ferent doses of IA RTX (10 ml of 0.001% and 10 ml of 0.0003%) 7 days prior
to induction of arthritis. Similarly, another group of mice was injected
with 10 ml of 0.01% IA CAP 7 days prior to induction of arthritis. DWB
was measured with a Dynamic Weight Bearing apparatus (Bioseb,
Vitrolles, France). Evoked pain behavior was measured by tallying ﬁghts
þ vocalizations/1 min with repeated ﬁrm palpation of the knee.Results: Increased EPS and reduced DWB measures were clear and
reproducible indicators of pain in the affected limbs of arthritic mice.
Naïve mice demonstrated low EPS scores (1.01) and equal left to right
DWB ratios for weight (1.01) and time (1.00). Induction of acute
arthritis by IA Carrageenan resulted in a signiﬁcantly increased EPS
(6.25) and a signiﬁcant decrease in left to right DWB ratios for weight
(0.64) and time (0.89) when compared with controls. Pretreatment
with IA CAP 7 days prior to IA Carrageenan resulted in signiﬁcant
improvement in EPS (3.25) and near normalization of left to right
DWB ratios for weight (0.975) and time (1.00). Pretreatment with the
high dose and the low dose IA RTX 7 days prior to IA Carrageenan leadto signiﬁcantly improved EPS (1.5 & 1.5, respectively) and left to right
DWB ratios for weight (0.85 & 0.82, respectively) and time (0.99 &
0.96, respectively) when compared with the acute arthritis model. IA
administration of CAP alone and RTX alone did not have a signiﬁcant
impact on EPS or DWB ratios after 7 days. Immunohistochemical (IHC)
evaluation of substance P in the spinal cord dorsal horn demonstrated
some differences between naive nonarthritic mice and both arthritic
and RTX treated mice.
Conclusions: DWB and EPS are sensitive and speciﬁc for quantita-
tion of pain in murine arthritis models. IA Carrageenan admin-
istration resulted in a signiﬁcant increase in EPS and a signiﬁcant
decrease in DWB measures in the affected limb. IA RTX pretreat-
ment in these mice clearly improved pain measures as assessed by
EPS and DWB measures and these results were comparable to those
previously reported for IA CAP. IA Carrageenan and IA RTX seem to
have an enhancing effect on substance P in the dorsal horn as
determined by IHC. The potential advantages RTX may have over
CAP include a possibly lower therapeutic dose and longer duration
of effect. These factors represent important directions for future
studies.
